Accession Number: | 0001209191-21-039819 |
Date: | 2021-06-09 |
Issuer: | NEOLEUKIN THERAPEUTICS, INC. (NLTX) |
Original Submission Date: |
WALKEY CARL
CO NEOLEUKIN THERAPEUTICS, INC.
188 EAST BLAINE STREET, #450
SEATTLE, WA 98102
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-09 | S | 650 | d | $10.82 | 1,353,089 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person. |
f2 | represents the weighted average sale price. the lowest price at which shares were sold was $10.81 and the highest price at which shares were sold was $11.00. the reporting person undertakes to provide upon request to the staff of the securities and exchange commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. |